BAFNA PHARM. Fact Sheet, BAFNA PHARM. Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAFNA PHARM. Fact Sheet    (BAFNPH)


Revealed: How Fund Managers Spot Winning Stocks


Here is the latest financial fact sheet of BAFNA PHARM.. For more details, see the BAFNA PHARM. quarterly results and BAFNA PHARM. share price and chart. For a sector overview, read our pharmaceuticals sector report.

BAFNA PHARMA Price History

Price Rs 157.0
Mkt Cap Rs m 3,713
Vol '000 6.7
P/E X 63.7
P/CF X 268.4
EPS (TTM) Rs 2.5
% ch % -3.9
No. of shares m 23.66
% ch week % 5.0
% ch 1-mth % 12.0
% ch 12-mth % 1,432.7
52 week H/L Rs 196.0/10.2
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BAFNA PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
BAFNA PHARMA EQUITY SHARE DATA
High Rs5236323011 
Low Rs24262095 
Sales per share (Unadj.) Rs45.234.119.918.4179.2 
Earnings per share (Unadj.) Rs-8.1-10.4-7.1-8.2-7.9 
Diluted earnings per shareRs-6.4-8.2-7.1-8.2-0.8 
Cash flow per share (Unadj.) Rs-5.5-8.2-5.5-6.75.8 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs30.920.716.08.1-17.9 
Adj. book value per shareRs24.416.316.08.1-1.8 
Shares outstanding (eoy) m18.6618.6623.6623.662.37 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.80.91.31.10 
Avg P/E ratio x-4.7-3.0-3.7-2.4-1.0 
P/CF ratio (eoy) x-6.9-3.8-4.8-2.91.3 
Price / Book Value ratio x1.21.51.62.4-0.4 
Dividend payout %00000 
Avg Mkt Cap Rs m71257962046218 
No. of employees `000NANANANANA 
Total wages/salary Rs m69687590103 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BAFNA PHARMA INCOME DATA
Net Sales Rs m843636472436425 
Other income Rs m201131343 
Total revenues Rs m862647785440427 
Gross profit Rs m5-58-351-13112 
Depreciation Rs m4942403533 
Interest Rs m13011569211 
Profit before tax Rs m-153-204-147-183-19 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-2-922110 
Profit after tax Rs m-151-195-169-194-19 
Gross profit margin %0.6-9.1-74.5-30.02.9 
Effective tax rate %1.24.4-14.9-5.80 
Net profit margin %-18.0-30.6-35.8-44.4-4.4 
BAFNA PHARMA BALANCE SHEET DATA
Current assets Rs m1,223772487485361 
Current liabilities Rs m950815598708171 
Net working cap to sales %32.4-6.7-23.5-51.244.7 
Current ratio x1.30.90.80.72.1 
Inventory Days Days733013462840 
Debtors Days Days29430918820852 
Net fixed assets Rs m6951,011896710352 
Share capital Rs m18718723723724 
"Free" reserves Rs m391200143-46-66 
Net worth Rs m578387379191-42 
Long term debt Rs m35239023223030 
Total assets Rs m1,9251,7831,3841,195713 
Interest coverage x-0.2-0.8-1.1-7.6-18.6 
Debt to equity ratio x0.61.00.61.2-0.7 
Sales to assets ratio x0.40.40.30.40.6 
Return on assets %-1.1-4.5-7.2-14.4-2.5 
Return on equity %-26.2-50.3-44.6-101.644.4 
Return on capital %-2.5-11.4-12.7-38.4146.1 
Exports to sales %00000 
Imports to sales %3.33.48.75.05.5 
Exports (fob) Rs m00000 
Imports (cif) Rs m2821412224 
Fx inflow Rs m287235207260250 
Fx outflow Rs m2921412224 
Net fx Rs m258214166239226 
BAFNA PHARMA CASH FLOW
From Operations Rs m 9 -9 -70 -18 -343 
From Investments Rs m -4 -54 380 154 328 
From Financial Activity Rs m -6 63 -306 -138 73 
Net Cashflow Rs m -1 -1 3 -2 58 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 90.4%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 9.6%
Shareholders 8,330
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Bafna Towers, New No 68 Old No.299, Thambu Chetty Street, Chennai - 600001
E-MAIL cs@bafnapharma.com WEB www.bafnapharma.com
TEL 044- 25267517/25270992 FAX 044- 25231264
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Cameo Corporate Services Ltd, Subramanian Buildings No 1, Club House Road
YEAR OF INC: 1995 BSE CODE: 532989 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   KIMS  IND SWIFT LA  CAPLIN POINT  MERCURY LAB.  HIKAL.  

Compare BAFNA PHARMA With:   KIMS  IND SWIFT LA  CAPLIN POINT  MERCURY LAB.  HIKAL.  




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BAFNA PHARMA

  • Track your investment in BAFNA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BAFNA PHARMA

BAFNA PHARMA - BROOKS LAB COMPARISON

COMPARE BAFNA PHARMA WITH

MARKET STATS